Prolonged administration may cause bone marrow depression, with agranulocytosis, thrombocytopenia, and aplastic anemia. Peripheral neuritis and depilation have also been reported.
Myopathy may occur in patients on usual maintenance doses, especially in the presence of renal impairment.
View ADR Monitoring Form